Biomedical Engineering Reference
In-Depth Information
Figure 43.15b.
H&E staining evaluation of specimen at 8 weeks after
implantation.Group1wasnotimplantedwithanykindoffibrin/humanBM
stem cells (sham operation). Group 2 was implanted with a fibrin glue scaf-
fold in the defect region. Group 3 was implanted with a fibrin/human BM
stem cells composite scaffold in the defect region.
43.3.2
Use of Bioreactors, Human Fetal Stem Cells, and 3D
Scaffolds for Bone Tissue Engineering
Cellsarethecentralplayersformostbiologicalprocessinthehuman
body and play the essential role in the BTE. The selection of cell
sources will eventually determine the clinical success of any BTE
Search WWH ::
Custom Search